AI helps to open new routes to earlier diagnosis and treatment of Crohn's disease
Scientists have combined artificial intelligence (AI), genetics and gut microbiome analysis to shed new light on one of the most serious complications of Crohn's disease: intestinal fibrosis, the irreversible scarring of the bowel that often leads to surgery.
Scientists from the University of Birmingham Dubai have utilized artificial intelligence (AI), genetics, and gut microbiome analysis to better understand intestinal fibrosis, a serious complication of Crohn's disease. The study, published in Frontiers in Artificial Intelligence, reveals that fibrosis is not a separate disease stage but rather a related inflammatory condition driven by ongoing immune activation, damage to the intestinal lining, and changes in gut bacteria.
By identifying a shared set of 43 key genes linked to disease progression, the researchers have pinpointed three major biological patterns that could serve as potential biomarkers for earlier diagnosis and treatment of Crohn's disease patients at high risk of fibrosis.
Brief written by urgent.news from Medical Xpress's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
